A-Alpha Bio is building a high-resolution model of biology by measuring protein interactions.

A-Alpha leverages its platform technology AlphaSeq to generate high-quality protein interaction data at scale, enabling the discovery of better drugs faster.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2021

• Founders

  • David Younger
  • Randolph Lopez

• Latest Tweets

  • Thank you to @frankvinluan at @medcitynews for featuring our latest collaboration with @bmsnews!… https://t.co/o2fwBLwmhi@AAlphaBio - 07:12 PM Aug 24th
  • We are excited to announce our collaboration with Bristol Myers Squibb (@bmsnews) to discover molecular glue target… https://t.co/izs1cMuQ9g@AAlphaBio - 01:19 PM Aug 23rd
  • A-Alpha Bio has been selected as a finalist for the annual @geekwire Awards Health Innovation of the Year! It's a f… https://t.co/FAqXQjQqJq@AAlphaBio - 02:16 AM Mar 29th